NM_000329.3(RPE65):c.993G>A (p.Trp331Ter) is a nonsense variant that introduces a premature stop codon into exon 9 of 14, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 2.800e-7 with 2 alleles / 1179940 total alleles in the European (Non-Finnish) population, which is lower than the ClinGen LCA / eoRD VCEP PM2_Supporting threshold of <0.0002 (PM2_Supporting). This variant has been reported in 1 proband with early-onset severe retinal dystrophy who harbored the variant in the homozygous state ( 0.5 points; PMID: 31725702). This variant has also been reported in 1 proband with early-onset severe retinal dystrophy who harbored the variant in the compound heterozygous state with NM_000329.3(RPE65):c.906_907del (p.Asn302LysfsTer17) (PMID: 26047050). This proband was not counted for this criterion (PM3) to avoid circularity. (0.5 total points, PM3_Supporting). At least one proband harboring this variant exhibits a phenotype including diagnosis of LCA (0.5 pts) with nystagmus (1 pt), hyperopia, granular white/gray pigment in mid-peripheral retina (2 pts), and extinguished rod (0.5 pts) and cone (1 pt) ERG. Screening of a gene panel with 163 genes did not reveal any additional variants of interest (2 pts). Together these phenotypes are specific for RPE65-related recessive retinopathy (total 7 points, PMID: 260 47050, PP4). The variant has been reported to segregate with childhood-onset severe retinal dystrophy through the proband plus 1 similarly affected relative, with the variant present in the compound heterozygous state (PP1; PMID: 26047050). In summary, this variant meets the criteria to be classified as Pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: PVS1, PM2_Supporting, PP4, PM3_Supporting, and PP1. (VCEP specifications version 1.0.0; date of approval 09/21/2023).